Hulya Kose

Prof. Dr. Hulya Kose

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2025 in Rheumatology
Verified
Journal Article
Closed access
KÖKübra Öztürk
Kübra Öztürk
TATuncay Aydin
Tuncay Aydin
GBGulcan Ozomay Baykal
Gulcan Ozomay Baykal
EBEsra Baglan
Esra Baglan
HKHulya Kose
Hulya Kose
EUErbil Unsal
Erbil Unsal
Objective: Juvenile idiopathic arthritis (JIA) is the most common chronic childhood arthritis, with distinct categories based on pathophysiology and clinical manifestations. The age of onset varies by category but is reported to be approximately six years. This study aimed to evaluate the clinical, laboratory and outcome characteristics of patients with infantile-onset JIA. Methods: This multicentre retrospective study included patients with JIA whose symptoms were onset before the age of two. Results: This study included 199 patients with a median age at symptom onset of 17 months and a median age at diagnosis of 20 months. The most common JIA categories were persistent oligoarticular (59.8%), systemic (13.6%) and rheumatoid factor (RF)-negative polyarticular (11.6%). Patients with symptom onset ≤12 months had a significantly higher prevalence of RF-negative polyarticular and systemic JIA, whereas those with onset >12 months had a higher prevalence of persistent oligoarticular JIA. Antinuclear antibody positivity was significantly higher in patients with disease onset >12 months, whereas uveitis development was more common in those with onset ≤12 months. The wrist, hand proximal interphalangeal (PIP) and foot PIP joints were significantly more frequently affected in patients with early-onset disease. At the last visit, 59.8% of the patients were in remission with medication and 18.1% were in remission without medication. Conclusion: This study suggests that patients with infantile-onset JIA exhibit distinct characteristics regarding JIA category, joint involvement and uveitis development, highlighting the need for further research and potential reconsideration of current age thresholds in the JIA classification.

30 December 2021 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
PDF file
HKHulya Kose
Hulya Kose
SKSara Sebnem Kilic
Sara Sebnem Kilic

8 July 2025 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
AAAkçahan Akalın
Akçahan Akalın
HKHatice Dilara Karakaş
Hatice Dilara Karakaş
CÇCanan Çelebi
Canan Çelebi
HKHulya Kose
Hulya Kose
EDEnise Avcı Durmuşalioğlu
Enise Avcı Durmuşalioğlu
PŞPelin Özlem Şimşek‐Kiper
Pelin Özlem Şimşek‐Kiper

1 January 2026 in Open Medicine
Verified
Journal Article
Open access
PDF file
TBTugce Bozkurt
Tugce Bozkurt
ASAbdurrahman Simsek
Abdurrahman Simsek
MKMuhammed ali Kızmaz
Muhammed ali Kızmaz
ECEren Cagan
Eren Cagan
HKHulya Kose
Hulya Kose
FBFerah Budak
Ferah Budak
Objectives: The COVID-19 pandemic has highlighted the importance of understanding immune regulation underlying disease severity. Adenosine deaminase (ADA), an enzyme with ADA1 and ADA2 isoforms, modulates immune responses and is mainly expressed in lymphoid tissues. This study examined ADA activity and its relationship with macrophage polarization in COVID-19. Methods: A total of 120 COVID-19 patients stratified by disease severity and 40 healthy controls were included. Total ADA (tADA), ADA1, and ADA2 activities were measured using the Giusti–Galanti colorimetric method in both patient sera and culture supernatants. Cytokine and chemokine profiles associated with M1- and M2-like macrophages were quantified by ELISA. To mechanistically evaluate macrophage polarization, naïve monocytes were co-cultured with SARS-CoV-2–responsive lymphocytes under a COVID-19 microenvironment (pCOV) generated using viral peptide pools in the presence of COVID-19 patient sera. Macrophage subsets were characterized by flow cytometry using canonical surface markers. The relationship between ADA2 activity and macrophage polarization was functionally assessed using pentostatin, whereas EHNA was used exclusively for the differential measurement of ADA isoenzyme activities. Results: Elevated total ADA activity was observed in critical patients, correlating with disease severity. Cytokine profiling revealed a hybrid M1/M2-like phenotype in severe cases, characterized by simultaneous pro- and anti-inflammatory mediator release. ADA2 activity showed a strong positive correlation with M2-associated factors, and flow cytometry confirmed the presence of CD206 + CD86 + hybrid macrophages. Conclusions: Overall, our findings suggest that ADA2 regulates macrophage plasticity in COVID-19, promoting M1/M2 hybrid polarization and contributing to immune dysregulation. ADA2 may serve as a biomarker for disease progression and a therapeutic target to modulate macrophage-driven inflammation in severe COVID-19.

29 February 2024 in Australasian Journal of Dermatology
Verified
Journal Article
Closed access
HKHulya Kose
Hulya Kose
MBMerve Deniz Baskaya
Merve Deniz Baskaya
SKSara Sebnem Kilic
Sara Sebnem Kilic

10 November 2024 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
HKHulya Kose
Hulya Kose
AAAkcahan Akalin
Akcahan Akalin
SKSara Sebnem Kilic
Sara Sebnem Kilic